Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2007
12/13/2007CA2654561A1 Novel aminoglycoside antibiotics
12/13/2007CA2654512A1 Low dose sublingual tablets of opioid analgesics and preparation process
12/13/2007CA2654509A1 Use of time-dependent antibiotics in the treatment of bacterial infections
12/13/2007CA2654450A1 Preparation and utility of substituted erythromycin analogs
12/13/2007CA2654445A1 Preparation and utility of substituted imidazopyridine compounds with hypnotic effects
12/13/2007CA2654370A1 Use of coumarin derivatives in antifungal therapy
12/13/2007CA2654352A1 Compositions comprising betulonic acid
12/13/2007CA2654318A1 Sulphimides as protein kinase inhibitors
12/13/2007CA2654303A1 Use of at least one polyphenol for promoting eye health
12/13/2007CA2654183A1 Compositions and methods for ameliorating hyperlipidemia
12/13/2007CA2654151A1 Drug administration methods
12/13/2007CA2654147A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia
12/13/2007CA2654138A1 Novel compounds
12/13/2007CA2654132A1 Compositions containing zinc salts for coating medical articles
12/13/2007CA2654126A1 Crystalline forms of 11.beta.-(4-acetylphenyl)-20,20,21,21,21-pentafluoro-17-hydroxy-19-nor-17.alpha.-pregna-4,9-dien-3-one
12/13/2007CA2654048A1 Treatment of gastrointestinal disorders with cgrp antagonists
12/13/2007CA2654047A1 Cgrp antagonists
12/13/2007CA2654026A1 Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischemia
12/13/2007CA2654008A1 Polymeric biosurfactants
12/13/2007CA2653955A1 Pharmaceutical compositions for sustained release of phenylephrine
12/13/2007CA2653953A1 Phenylephrine pharmaceutical formulations and compositions for colonic absorption
12/13/2007CA2653950A1 Phenylephrine pulsed release formulations and pharmaceutical compositions
12/13/2007CA2653940A1 Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
12/13/2007CA2653936A1 Sustained release pharmaceutical dosage form containing phenylephrine
12/13/2007CA2653869A1 Salts of trimebutine and n-desmethyl trimebutine
12/13/2007CA2653827A1 Novel blonanserin tape preparation
12/13/2007CA2653787A1 Composition for preventing the occurrence of cardiovascular event in multiple risk patient
12/13/2007CA2653774A1 2-thioxanthine derivatives acting as mpo-inhibitors
12/13/2007CA2653772A1 9,10-secopregnane derivative and pharmaceutical
12/13/2007CA2653655A1 Organic compounds
12/13/2007CA2653625A1 Controlled release formulations
12/13/2007CA2653527A1 New salts and crystalline salt forms of an indolinone derivative
12/13/2007CA2653485A1 Prednisolone salt formulations
12/13/2007CA2653480A1 Prednisolone salt formulations
12/13/2007CA2653463A1 Methods for preparing glutamic acid derivatives and intermediates thereof
12/13/2007CA2653429A1 Novel method for preparation of ammonium salts of esomeprazole
12/13/2007CA2653424A1 Novel indazole derivative having spiro ring structure in side chain
12/13/2007CA2653366A1 Delivery method
12/13/2007CA2653347A1 Alcohol-containing antimicrobial compositions having improved efficacy
12/13/2007CA2653345A1 Ibudilast for inhibiting macrophage migration inhibitory factor (mif) activity
12/13/2007CA2653238A1 Pyrrolidine derivatives useful as bace inhibitors
12/13/2007CA2653237A1 Use of vascular endothelial growth factor receptor inhibitors for the treatment of cancer
12/13/2007CA2653206A1 Transporter-enhanced corticosteroid activity
12/13/2007CA2652712A1 Stabilized pharmaceutical compositions comprising fesoterodine
12/13/2007CA2652667A1 Therapeutic combination for painful medical conditions
12/13/2007CA2652620A1 Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof
12/13/2007CA2651550A1 Fused, tricyclic sulfonamide inhibitors of gamma secretase
12/13/2007CA2651519A1 Organic compounds
12/13/2007CA2651042A1 Compounds and methods for modulating expression of sglt2
12/13/2007CA2650082A1 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands
12/13/2007CA2648645A1 Utilisation d'un antagoniste des recepteurs cb1 aux cannabinoides pour la preparation de medicaments utiles pour la prevention et le traitement de l'hypertrophie benigne de la prostate
12/13/2007CA2640876A1 Process for the preparation of metoprolol and its salts
12/13/2007CA2630099A1 Self-assembling monomers and oligomers as surface-modifying endgroups for polymers
12/13/2007CA2589393A1 Ligand for g-protein coupled receptor gpr72 and uses thereof
12/12/2007EP1865319A1 Method of testing whether a tumor is susceptible to treatment with a ginkgo biloba extract or Ginkgolide B by testing whether the cancer is characterized by an over-expression of peripheral-type benzodiazepine receptor protein
12/12/2007EP1864997A1 ROR ALPHA PROMOTING THE INDUCTION OF Bmal1 EXPRESSION
12/12/2007EP1864992A2 Monosaccharide derivatives
12/12/2007EP1864986A1 Pyrazolopyrimidine derivative or pharmaceutically acceptable salt thereof
12/12/2007EP1864985A1 Novel carbapenem compound
12/12/2007EP1864984A1 Tricyclic spiro compound comprising acyl group bound to nitrogen atom in the ring
12/12/2007EP1864983A1 Pyrimidine compounds as cyclin-dependent kinase inhibitors
12/12/2007EP1864982A1 Triamine derivative
12/12/2007EP1864981A1 Thrombopoietin mimetics
12/12/2007EP1864980A1 Antifungal agent containing pyridine derivative
12/12/2007EP1864979A1 Imidazole-derivatives as TAFAIa-inhibitors
12/12/2007EP1864977A1 Novel cyclic compound having pyrimidinylalkylthio group
12/12/2007EP1864976A1 Propane-1,3-dion derivative or salt thereof
12/12/2007EP1864975A2 Novel compounds
12/12/2007EP1864974A1 Potentiator for radiation therapy comprising pyridine derivative as active ingredient
12/12/2007EP1864972A1 Bcrp/abcg2 inhibitor
12/12/2007EP1864971A1 Prophylactic/therapeutic agent for diabetes
12/12/2007EP1864967A1 Method for preparing O-desmethyl-venlafaxine
12/12/2007EP1864683A1 Radiotherapy enhancer
12/12/2007EP1864680A2 Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
12/12/2007EP1864677A1 Stable formulation comprising a moisture sensitive drug and manufacturing procedure thereof
12/12/2007EP1864670A1 Sucrase activity inhibitor, glucoamylase activity inhibitor and food and feed containing the same
12/12/2007EP1864669A1 Application of d-psicose to suppression of abnormal circadian increase in blood glucose level
12/12/2007EP1864668A1 Use of prodrugs for ocular intravitreous administration
12/12/2007EP1864667A1 Use of prodrugs for ocular intravitreous administration
12/12/2007EP1864666A1 Protective agent for retinal neuronal cell containing prostaglandin f2 alpha derivative as active ingredient
12/12/2007EP1864665A1 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
12/12/2007EP1864664A1 Pharmaceutical preparation
12/12/2007EP1864663A1 Preventive and/or therapeutic agent for rheumatoid arthritis
12/12/2007EP1864662A1 Therapeutic agent for thrombosis
12/12/2007EP1864661A1 Prophylactic/therapeutic agent for stress-induced bowel disease
12/12/2007EP1864660A2 Medical compositions for intravesical treatment of bladder cancer
12/12/2007EP1864659A1 Lignane compound-containing oil-in-water emulsion and composition comprising the same
12/12/2007EP1864658A1 Agent for alleviating vascular insufficiency
12/12/2007EP1864657A1 Treatment of cutaneous neurogenic inflammation
12/12/2007EP1864655A1 Adhesive and adhesive patch
12/12/2007EP1864654A1 Infant formula compositions containing lutein and zeaxanthin
12/12/2007EP1864131A2 Natural ligand of g protein coupled receptor rcc356 and uses thereof
12/12/2007EP1863906A1 Use of a combination of myxoma virus and rapamycin for therapeutic treatment
12/12/2007EP1863827A1 Hydrogels for the controlled release of bioactive materials
12/12/2007EP1863820A1 Thioamide-substituted tricyclic benzimidazoles useful for the treatment of gastrointestinal diseases
12/12/2007EP1863819A2 Diazabicyclic aryl derivatives and their use as chinolinergic ligands at the nicotinic acetylcholine receptors
12/12/2007EP1863818A1 Acetylenyl-pyrazolo-pvrimidine derivatives as mglur2 antagonists
12/12/2007EP1863817A1 Substituted, bicyclic 8-pyrrolidino-benzimidazoles, method for their production and their use as medicaments
12/12/2007EP1863816A2 Synthesis and purification of pteroic acid and conjugates thereof
12/12/2007EP1863815A1 Substituted 9-alkyladenines and the use thereof
1 ... 3462 3463 3464 3465 3466 3467 3468 3469 3470 3471 3472 3473 3474 3475 3476 3477 3478 3479 3480 3481 3482 ... 7860